is a prostate health formula contains a unique blend of highly selected ingredients to promote healthy prostate function and supports normal urine flow.
Has been extensively utilized for the management of lower urinary tract symptoms secondary to BPH. In addition to the inhibition of 5α-reductase, the pharmacological effects of SPE include antiandrogenic effects, antiprolifera¬tive effects, and anti-inflammatory effects.
New Study Shows Euromed’s Saw Palmetto Extract To Be As Bioactive As A Leading Prescription Drug for Maintaining Prostate Health Published in April, 2016 in Research and Reports in Urology
A novel extract from Boswellia serrata, has demonstrated potential in prostate health protection.
5-LOXIN® acts as a powerful 5-lipoxygenase inhibitor. The enzyme 5-lipoxygenase (5-LOX) inflicts numerous adverse effects that have been implicated in prostate cancer development.
Boswellia extract also favorably modulates gene expression, powerfully suppressing production of pro-inflammatory cytokines involved in BPH and Prostate cancer.
This extract also blocks prostate cancer growth and proliferation in cell Cultures. These effects are due in part to its ability to decrease the androgen Receptors that many prostate cancers require to survive.
Boswellia extracts also inhibit new blood vessel growth (angiogenesis), Depriving malignant tissues of the nutrients and oxygen they need to metastasize.
A number of studies have found stinging nettle root (Urtica Dioica) to be effective At promoting normal prostate size and relieving the urinary symptoms associated with an enlarged and aging prostate. Which include urinary frequency, incontinence, urination at night, not being able to empty the bladder completely, Waiting for the stream to begin, and a urinary stream that starts and stops.
Pumpkin seeds are shown to promote a healthy prostate due to their high levels of Essential fatty acids, zinc and phytosterols.
Beta-sitosterol, found in pumpkin seeds, is believed to inhibit the enzyme 5 α –reductase involved in the conversion of testosterone (a sex hormone) to Dihydrotestosterone which can promote excessive prostate growth.
Lycopene inhibits androgen receptor expression in prostate cancer cells in vitro and, Along with some of its metabolites, reduces prostate cancer cell proliferation and may Modulate cell-cycle progression.
Clinical trials utilizing lycopene in prostate cancer patients with various different Clinical presentations (e.g., early stage, prostate-specific antigen (PSA) relapse, Advanced disease) have yielded inconsistent results.
Green tea catechins (GTCs) include (−)-epigallocatechin-3-gallate (EGCG), (−)-epicatechin (EC), (−)-epigallocatechin (EGC), and (−)-epicatechin-3-gallate (ECG).
Laboratory, preclinical, and early-phase clinical trials have identified EGCG as one of the most potent modulators of molecular pathways thought to be relevant to prostate carcinogenesis. EGCG has been shown to act as an androgen antagonist and can suppress prostate cancer cell proliferation, suppress production of Prostate-specific antigen (PSA) by prostate cancer cells, and demonstrate potent and selective proapoptotic activity in prostate cancer cell lines in vitro.
Recommended Dosage: Take the content of one sachet (2 capsules) once daily or as recommended by your physician.